scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1526-4610.1998.3807497.X |
P8608 | Fatcat ID | release_3hg5vbpq2zb77clkicyfhk66dy |
P698 | PubMed publication ID | 15613165 |
P5875 | ResearchGate publication ID | 8117512 |
P50 | author | Ann Scher | Q73888500 |
Richard B. Lipton | Q56957375 | ||
P2093 | author name string | Stewart WF | |
Liberman J | |||
P433 | issue | 7 | |
P921 | main subject | headache | Q86 |
P304 | page(s) | 497-506 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Headache | Q5689497 |
P1476 | title | Prevalence of frequent headache in a population sample. | |
P478 | volume | 38 |
Q34223262 | 'I saw a great star, most splendid and beautiful': headache in primary care. |
Q50784096 | A 13-year long-term outcome study of elderly with chronic daily headache. |
Q37606753 | A Review of Select Centralized Pain Syndromes: Relationship With Childhood Sexual Abuse, Opiate Prescribing, and Treatment Implications for the Primary Care Physician |
Q34223243 | A murky future for academic primary care |
Q41886089 | A new mutation in GFAP widens the spectrum of Alexander disease |
Q44004727 | A prospective study of prevalence and characterization of headache following mild traumatic brain injury |
Q46941997 | A randomized trial of telephone-based motivational interviewing for adolescent chronic headache with medication overuse |
Q33825539 | Acupuncture for Improving Chronic Back Pain, Osteoarthritis and Headache. |
Q39742896 | An epidemiological study of headache in Florianopolis, Brazil |
Q38338390 | Approach to chronic daily headache |
Q44885760 | Are headache and temporomandibular disorders related? A blinded study |
Q73172384 | Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine |
Q39672066 | Association between adolescent chronic daily headache and childhood adversity: a community-based study. |
Q35696699 | Associations of socioeconomic status with migraine and non-migraine headache |
Q35524297 | BMI and headache among women: results from 11 epidemiologic datasets |
Q38069513 | Behavioral therapy for chronic migraine. |
Q53860656 | Botox therapy for refractory chronic migraine. |
Q47276717 | Botulinum neurotoxin for the treatment of migraine and other primary headache disorders |
Q35187508 | Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside |
Q33974749 | Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study |
Q36488226 | Botulinum toxin type A for the treatment of migraine |
Q42653763 | Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study |
Q34579591 | Burden of tension-type headache |
Q34548447 | Butalbital-containing agents: should they be banned? No. |
Q36773365 | Causality and headache triggers |
Q39167460 | Central and Peripheral Neural Targets for Neurostimulation of Chronic Headaches |
Q49083710 | Cerebrovascular risk factors and MRI abnormalities in migraine |
Q35632844 | Children and adolescents with chronic daily headache |
Q79095635 | Chronic Daily Headache |
Q37124323 | Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study |
Q57665872 | Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors |
Q74473087 | Chronic daily headache |
Q77776526 | Chronic daily headache |
Q35632835 | Chronic daily headache and the revised international headache society classification |
Q39858510 | Chronic daily headache in Brazil: a nationwide population-based study. |
Q33911693 | Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management |
Q39642874 | Chronic daily headache in U.S. soldiers after concussion |
Q53312600 | Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. |
Q50957620 | Chronic daily headache in children and adolescents: a clinic based study from India. |
Q38156669 | Chronic daily headache in the elderly |
Q44471498 | Chronic daily headache in the posttrauma syndrome: relation to extent of head injury |
Q44093885 | Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study |
Q44249091 | Chronic daily headache: identification of factors associated with induction and transformation |
Q53154336 | Chronic daily headache: stress and impact on the quality of life. |
Q37155946 | Chronic daily headache: transformational migraine, chronic migraine, and related disorders |
Q80197024 | Chronic daily headaches in children |
Q28196343 | Chronic daily headaches: clinical profile in Indian patients |
Q53217214 | Chronic frequent headache in the general population: comorbidity and quality of life. |
Q51776151 | Chronic frequent headache in the general population: prevalence and associated factors. |
Q34987149 | Chronic headache and sleep disturbance |
Q38033143 | Chronic headaches and insomnia: working toward a biobehavioral model |
Q38364187 | Chronic migraine - new treatment options |
Q38066464 | Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review |
Q36102253 | Chronic migraine and medication-overuse headache through the ages |
Q45395151 | Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study |
Q44199010 | Chronic migraine, classification, differential diagnosis, and epidemiology |
Q45065395 | Chronic migraine: classification and comparisons |
Q37363477 | Chronic migraine: current pathophysiologic concepts as targets for treatment |
Q37808388 | Chronic migraine: epidemiology and disease burden |
Q38889450 | Chronic migraine: risk factors, mechanisms and treatment |
Q37155941 | Chronic pain rehabilitation in chronic headache disorders |
Q37363479 | Chronic pain rehabilitation in chronic headache disorders |
Q84847291 | Chronic tension-type headache |
Q45952969 | Clinical characteristics of tension-type headache in the neurological clinic of a university hospital in China. |
Q34987131 | Cognitive-behavioral issues in the treatment and management of chronic daily headache |
Q57665880 | Comorbidity of Depressive and Anxiety Disorders in Chronic Daily Headache and Its Subtypes |
Q38673055 | Conceptualizing a subtype of patients with chronic pain: The necessity of obtaining a history of sexual abuse |
Q37781206 | Consensus Statement: The Development of a National Canadian Migraine Strategy |
Q34200781 | Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). |
Q48248491 | Craniofacial pain and jaw-muscle activity during sleep |
Q28271614 | DHE in the pharmacotherapy of migraine: potential for a larger role |
Q27027006 | Development of onabotulinumtoxinA for chronic migraine |
Q38143665 | Dietary considerations in migraine management: does a consistent diet improve migraine? |
Q35056865 | Disease modification in migraine: a concept that has come of age? |
Q44326422 | Does chronic daily headache arise de novo in association with regular use of analgesics? |
Q33643462 | Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial |
Q77789956 | Drug-associated headache is unrecognized in patients treated at a neurological centre |
Q28219436 | EFNS guideline on the drug treatment of migraine - report of an EFNS task force |
Q79813622 | Effectiveness of a multidisciplinary treatment program for chronic daily headache |
Q28188297 | Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study |
Q46823823 | Emotional problems and prevalence of medication overuse in pediatric chronic daily headache |
Q39651022 | Epidemiological and clinical characteristics of migraine and tension type headache in 1146 females in Kayseri, Turkey |
Q37791924 | Epidemiological classification and social impact of chronic headache |
Q36847280 | Epidemiological profiles of patients with chronic migraine and chronic tension-type headache |
Q37791877 | Epidemiology of Tension-type Headache |
Q34417818 | Epidemiology of chronic daily headache |
Q34135940 | Epidemiology of headache |
Q34176914 | Epidemiology of migraine and other types of headache in Asia |
Q35632840 | Estrogen and chronic daily headache |
Q36106987 | Evaluation and management of headache in primary care |
Q34770974 | Evidence for an association between migraine and the hypocretin receptor 1 gene |
Q36641577 | Evidence-based understanding of medication-overuse headache: clinical implications |
Q42370318 | Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
Q44452257 | Frequency of headache among the employees of a rubber company in the state of São Paulo, Brazil. |
Q36259584 | From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries |
Q36947165 | From migraine to chronic daily headache: the biological basis of headache transformation |
Q30431235 | Gender-based comorbidity in benign paroxysmal positional vertigo |
Q34992795 | Global prevalence of chronic migraine: a systematic review |
Q47867976 | Grinding patterns in migraine patients with sleep bruxism: a case-controlled study |
Q37694550 | Headache and medication overuse: are clinical case series appropriate to reveal differential risks of different medications? |
Q45178084 | Headache disorders in the millennium cohort: epidemiology and relations with combat deployment. |
Q38236801 | Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experience |
Q34222164 | Headache in primary care: how important is diagnosis to management? |
Q37750563 | Headache in the elderly: primary forms |
Q53220258 | Headaches in a rheumatology clinic: when one pain leads to another. |
Q37107742 | Homeopathic treatment of headaches: a systematic review of the literature |
Q34350027 | Impact of GP direct-access computerised tomography for the investigation of chronic daily headache |
Q34507965 | Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations |
Q36617354 | Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM). |
Q35756332 | Inpatient treatment of headache: an evidence-based assessment |
Q44776564 | Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse |
Q24596291 | Investigating the genetic role of aquaporin4 gene in migraine |
Q48763065 | Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI. |
Q34600093 | Is Chiari type I malformation a reason for chronic daily headache |
Q37750558 | Is chronic migraine a primary or a secondary condition? |
Q37698336 | Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? |
Q37263400 | Is migraine a neuropathic pain syndrome? |
Q48022783 | Is obstructive sleep apnea syndrome associated with headache? |
Q36037400 | Is there a relationship between throbbing pain and arterial pulsations? |
Q39238901 | Lagniappe: the impact of headache disorders in America |
Q38033658 | Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders |
Q34987458 | Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial |
Q57421286 | Major Life Changes Before and After the Onset of Chronic Daily Headache: A Population-Based Study |
Q36099528 | Management of chronic daily headache: challenges in clinical practice |
Q37744888 | Management of headache in the elderly |
Q36941902 | Management of medication-overuse headache |
Q37703852 | Medication Overuse Headache: The Reason of Headache That Common and Preventable |
Q38509398 | Medication overuse and chronic migraine: a critical review according to clinical pharmacology |
Q35933709 | Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management |
Q50270208 | Medication-overuse headache. Despite the advances in understanding it, treatment evidence still lacks |
Q34192963 | Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment |
Q46794724 | Migraine and Complex Regional Pain Syndrome: A Case-Referent Clinical Study. |
Q36855988 | Migraine and chronic daily headache management: implications for primary care practitioners. |
Q37049710 | Migraine, tension-type headache, and transformed migraine |
Q28165454 | Migraine: diagnosis and management |
Q35930154 | Myofascial pain: diagnosis and management |
Q43551354 | Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. |
Q35129772 | Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases |
Q35212565 | Natural history of headache after traumatic brain injury |
Q52856790 | Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). |
Q26752211 | Neurostimulation in the treatment of primary headaches |
Q48623265 | Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine |
Q46459487 | New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors |
Q37738323 | New daily persistent headache in children and adolescents |
Q45116094 | New daily persistent headache in the paediatric population |
Q52355216 | Non-Rapid Eye Movement Sleep Parasomnias and Migraine: A Role of Orexinergic Projections. |
Q22252594 | Obesity and chronic daily headache |
Q37139982 | Occipital nerve stimulation for medically intractable headache. |
Q24614459 | Occipital nerve stimulation in primary headache syndromes |
Q35822040 | OnabotulinumtoxinA for chronic migraine: a critical appraisal. |
Q47187117 | One-year prevalence and socio-cultural aspects of chronic headache in Turkish immigrants and German natives |
Q35742581 | One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults |
Q43551363 | Opiate use to control bowel motility may induce chronic daily headache in patients with migraine |
Q35044048 | Opioid resistance in chronic daily headache: a synthesis of ideas from the bench and bedside |
Q37052803 | Optimizing prophylactic treatment of migraine: Subtypes and patient matching |
Q37544942 | Overuse of acute migraine medications and migraine chronification |
Q89110506 | Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm |
Q37858847 | Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies |
Q35124467 | Pathophysiology, epidemiology, and impact of migraine |
Q47326072 | Patients with chronic headache tend to have more psychological symptoms than those with sporadic episodes of pain |
Q44755363 | Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study |
Q34194885 | Pericranial tenderness in chronic tension-type headache: the Akershus population-based study of chronic headache |
Q38215469 | Peripheral neurostimulation in primary headaches |
Q36750237 | Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center |
Q34619560 | Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. |
Q39368081 | Placebo response in a patient with chronic migraine and ergotic overuse |
Q53463490 | Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. |
Q38110585 | Post-traumatic headaches in civilians and military personnel: a comparative, clinical review |
Q48568248 | Predictive Factors of Headache Resolution After Chiari Type 1 Malformation Surgery |
Q39832939 | Prevalence and associated factors for episodic and chronic daily headache in the Colombian population |
Q53306593 | Prevalence and clinical characteristics of headache in a rural community in Oman. |
Q45804186 | Prevalence of chronic migraine and medication overuse headache in Germany--the German DMKG headache study |
Q73676253 | Prevalence of head trauma in patients with difficult headache: the North Norway Headache Study |
Q35461371 | Prevalence of headache in an elderly population: attack frequency, disability, and use of medication |
Q36259784 | Prevalence of migraine and tension-type headache among adults in Jordan |
Q43942778 | Prevalence of migraine headache in a rural area of northern Tanzania: a community-based door-to-door survey |
Q35851287 | Prevalence of primary headaches in Germany: results of the German Headache Consortium Study |
Q53215137 | Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. |
Q39765033 | Preventive medication adherence in African American and Caucasian headache patients |
Q86606657 | Primary Headache Disorders: Focus on Migraine |
Q37577403 | Primary headache disorders at a tertiary health facility in Lagos, Nigeria: prevalence and consultation patterns |
Q34981799 | Primary headaches in patients with generalized anxiety disorder |
Q34570686 | Primary headaches: a convergence hypothesis |
Q36285004 | Productivity losses attributable to headache, and their attempted recovery, in a heavy-manufacturing workforce in Turkey: implications for employers and politicians |
Q36259780 | Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk |
Q34987155 | Psychiatric comorbidity of chronic daily headache: impact, treatment, outcome, and future studies |
Q52900807 | Psychosocial headache measures in Caucasian and African American headache patients: Psychometric attributes and measurement invariance |
Q37270891 | Putative mechanisms of the relationship between obesity and migraine progression |
Q37861402 | Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. |
Q51965402 | Quality-of-life differences between patients with episodic and transformed migraine. |
Q34223253 | Racism and general practice--time to grasp the nettle. |
Q40081930 | Rational combination therapy in refractory migraine |
Q37760087 | Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? |
Q47629134 | Remission of chronic headache: Rates, potential predictors and the role of medication, follow-up results of the German Headache Consortium (GHC) Study |
Q34987140 | Risk factors for chronic daily headache |
Q38270464 | Risk factors of chronic daily headache or chronic migraine |
Q37079889 | Safety and efficacy of cervical 10 kHz spinal cord stimulation in chronic refractory primary headaches: a retrospective case series |
Q51229352 | Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. |
Q34548454 | Should butalbital-containing analgesics be banned? Yes. |
Q38014279 | Sinus venous stenosis, intracranial hypertension and progression of primary headaches. |
Q44955629 | Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache. |
Q35952266 | Southern Headache Society supplement: the neurobiology of throbbing pain in migraine. |
Q34375888 | Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care |
Q33661852 | Studying sex and gender differences in pain and analgesia: a consensus report. |
Q46451937 | Survey of career satisfaction, lifestyle, and stress levels among pharmacy school faculty |
Q37544950 | Temporomandibular disorders and migraine chronification |
Q38006001 | Temporomandibular disorders, facial pain, and headaches |
Q58416751 | Temporomandibular disorders, headaches, and cervical pain among females in a Sami population |
Q24681276 | Tension-type headache |
Q36310998 | Tension-type headache: classification and diagnosis |
Q37703839 | The Face of Chronic Migraine Which Has Started to be Clarified |
Q53242572 | The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic. |
Q51729056 | The burden of headache in neurology outpatient clinics in Turkey. |
Q44778753 | The course of migraine-a diary study in unselected patients |
Q36978871 | The differential diagnosis of chronic daily headaches: an algorithm-based approach |
Q37363473 | The epidemiology of chronic daily headache. |
Q35603266 | The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results |
Q41713495 | The lesson of chronic migraine. |
Q37202602 | The molecular epidemiology of pain: a new discipline for drug discovery |
Q37900861 | The paradoxical effects of analgesics and the development of chronic migraine |
Q52547141 | The post-concussion syndrome in Lithuania redux. |
Q43415755 | The prevalence of chronic and episodic migraine in children and adolescents |
Q40025115 | The prevalence of primary headache disorders in Russia: a countrywide survey. |
Q35930165 | The tension headache component of chronic daily headache |
Q36259609 | The validation of ID Migraine screener in neurology outpatient clinics in Turkey |
Q37925042 | Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes and mechanisms |
Q34180705 | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
Q43280719 | Topiramate modulates excitability of the occipital cortex when measured by transcranial magnetic stimulation |
Q40091928 | Toward an epidemiology of refractory migraine: current knowledge and issues for future research |
Q44904189 | Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes |
Q60686314 | Treatment of PTSD and Chronic Daily Headache |
Q37610200 | Treatment of chronic overmedicated headache patients. |
Q40115943 | Treatment of comorbidities of chronic daily headache |
Q38540076 | Treatment of medication-overuse headache: A systematic review |
Q37940623 | Treatment of refractory pain with botulinum toxins--an evidence-based review |
Q47341690 | Update on Chronic Daily Headache |
Q37041473 | Use of the emergency department for severe headache. A population-based study |
Q34322063 | Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache |
Q45848975 | Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine |
Q51532415 | Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs. |
Q34375878 | What do patients want from acute migraine treatment? |
Q37784245 | What is the Role of Dependence‐Related Behavior in Medication‐Overuse Headache? |
Q34154642 | What is the evolutionary advantage of migraine? |
Q36419551 | When migraine progresses: transformed or chronic migraine |
Q79820482 | [Daily chronic headaches related to excessive ingestion of medicinal products] |
Search more.